Quick Summary:
As global entities strive to personalize medicine, identify hereditary diseases, and take preventive steps, they are increasingly turning to the gene panel market. This comprehensive research report offers an in-depth examination of this flourishing market, including analysis of major market vendors, geographical breakdowns, and the segmentation by product and technique. Our report provides valuable insights for business leaders seeking a thorough understanding of the currently unfolding market scenario and dominant trends.
Key market drivers are the growing application of gene panels in targeted cancer therapies, the increase in people suffering from genetic disorders, and the decreasing cost of Next Generation Sequencing (NGS) gene panel tests. The aggregated data from primary and secondary sources provides both qualitative and quantitative research, making this report a vital tool for accurate forecasting of market growth. This reliable, meticulous study supports businesses in strategizing and leveraging forthcoming growth opportunities in the gene panel market.
1h Free Analyst Time
The gene panel market is forecasted to grow by USD 3236.87 mn during 2022-2027, accelerating at a CAGR of 18.21% during the forecast period. The report on the gene panel market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing use of gene panels in cancer-targeted therapies, increasing number of people with genetic disorders, and decreasing cost of next generation sequencing (NGS) gene panel tests.
The gene panel market is segmented as below:
By Product
- Small panel testing
- Large panel testing
By Technique
- Amplicon
- Hybridization
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the gene panel market covers the following areas:
- Gene panel market sizing
- Gene panel market forecast
- Gene panel market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Technique
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global gene panel market: Agilent Technologies Inc., Azenta Inc., CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fagron NV, GenXPro GmbH, Illumina Inc., Invitae Corp., MedGenome Labs Ltd., MGZ Medizinisch Genetisches Zentrum, Novogene Co. Ltd., OPKO Health Inc., Oxford Nanopore Technologies plc, QIAGEN NV, Quest Diagnostics Inc., Thermo Fisher Scientific Inc., and BGI Genomics Co. Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is collaboration to maximize research efficiency.'
According to the report, one of the major drivers for this market is the decreasing cost of next generation sequencing (NGS) gene panel tests.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Agilent Technologies Inc.
- Azenta Inc.
- CENTOGENE NV
- Color Health Inc.
- Danaher Corp.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Fagron NV
- GenXPro GmbH
- Illumina Inc.
- Invitae Corp.
- MedGenome Labs Ltd.
- MGZ Medizinisch Genetisches Zentrum
- Novogene Co. Ltd.
- OPKO Health Inc.
- Oxford Nanopore Technologies plc
- QIAGEN NV
- Quest Diagnostics Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics Co. Ltd.
